Literature DB >> 21700938

Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury.

Cindy T J van Velthoven1, Cobi J Heijnen, Frank van Bel, Annemieke Kavelaars.   

Abstract

BACKGROUND AND
PURPOSE: Hypoxic-ischemic (HI) brain injury is a frequent cause of perinatal morbidity and mortality with limited therapeutic options. To identify molecules important for cerebral damage and repair, we investigated the growth factor-related gene expression profile after neonatal cerebral HI. We identified osteopontin (OPN) as the most highly upregulated factor early after HI. We therefore explored the role of endogenous OPN in brain damage and repair.
METHODS: Nine-day-old wild-type mice were exposed to cerebral HI; growth factor-related gene expression profiles were analyzed 1 to 7 days later by reverse transcriptase-polymerase chain reaction arrays. To determine the contribution of OPN to brain damage, we used p9 OPN(-/-) and wild-type mice. HI brain damage, sensorimotor function, and cell proliferation and differentiation were compared.
RESULTS: Gene expression profiling of 150 genes related to growth factors and neurotrophins showed that expression of 52 genes changed during the first 7 days after HI. OPN was the gene with the strongest increase expression at all time points measured. We show here for the first time that in response to neonatal HI, OPN-deficient mice developed increased gray and white matter loss and more pronounced sensorimotor deficits as compared with wild-type littermates. Furthermore, OPN deficiency decreases HI-induced cell proliferation/survival and oligodendrogenesis without affecting neuronal differentiation.
CONCLUSIONS: OPN plays an important role in repairing brain injury after neonatal HI by regulating cerebral cell proliferation/survival and oligodendrocyte differentiation after injury. The observed promyelinative effect of OPN may offer novel possibilities for a therapy targeting white matter injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21700938     DOI: 10.1161/STROKEAHA.110.608315

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

Authors:  Julie L Chan; Thomas M Reeves; Linda L Phillips
Journal:  Exp Neurol       Date:  2014-08-21       Impact factor: 5.330

2.  Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.

Authors:  Yin-Chuan Jin; Hahnbie Lee; Seung-Woo Kim; Il-Doo Kim; Hye-Kyung Lee; Yunjin Lee; Pyung-Lim Han; Ja-Kyeong Lee
Journal:  Mol Neurobiol       Date:  2015-10-19       Impact factor: 5.590

3.  Osteopontin Mediates Hyperbaric Oxygen Preconditioning-Induced Neuroprotection Against Ischemic Stroke.

Authors:  Sheng-Li Hu; Yu-Xing Huang; Rong Hu; Fei Li; Hua Feng
Journal:  Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.590

4.  Sustained expression of osteopontin is closely associated with calcium deposits in the rat hippocampus after transient forebrain ischemia.

Authors:  Jang-Mi Park; Yoo-Jin Shin; Hong Lim Kim; Jeong Min Cho; Mun-Yong Lee
Journal:  J Histochem Cytochem       Date:  2012-04-11       Impact factor: 2.479

5.  Secreted ectodomain of sialic acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity.

Authors:  Kohki Matsubara; Yoshihiro Matsushita; Kiyoshi Sakai; Fumiya Kano; Megumi Kondo; Mariko Noda; Noboru Hashimoto; Shiro Imagama; Naoki Ishiguro; Akio Suzumura; Minoru Ueda; Koichi Furukawa; Akihito Yamamoto
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

6.  Plasma osteopontin may predict neuroinflammation and the severity of pediatric traumatic brain injury.

Authors:  Ning Gao; Xiaohui Zhang-Brotzge; Bushra Wali; Iqbal Sayeed; Joshua J Chern; Laura S Blackwell; Chia-Yi Kuan; Andrew Reisner
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-13       Impact factor: 6.200

Review 7.  The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment.

Authors:  Vanessa Donega; Cindy T J van Velthoven; Cora H Nijboer; Annemieke Kavelaars; Cobi J Heijnen
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-13       Impact factor: 6.200

Review 8.  Perlecan domain V therapy for stroke: a beacon of hope?

Authors:  Gregory J Bix
Journal:  ACS Chem Neurosci       Date:  2012-12-24       Impact factor: 4.418

9.  OSTEOPONTIN: A KEY LINK BETWEEN IMMUNITY, INFLAMMATION AND THE CENTRAL NERVOUS SYSTEM.

Authors:  Amanda Brown
Journal:  Transl Neurosci       Date:  2012-02-01       Impact factor: 1.757

10.  Association Between Osteopontin Gene Polymorphisms and Cerebral Palsy in a Chinese Population.

Authors:  Qing Shang; Chongchen Zhou; Dongzhi Liu; Wenxia Li; Mingjie Chen; Yiran Xu; Fei Wang; Dan Bi; Xiaoli Zhang; Xinzhi Zhao; Lei Wang; Changlian Zhu; Qinghe Xing
Journal:  Neuromolecular Med       Date:  2016-04-25       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.